The Future of Everything

Best of: The future of exercise

34 snips
Jan 3, 2025
Jonathan Long, a Stanford biochemist, dives into the fascinating world of exercise chemistry and its profound effects on health. He discusses the evolution of weight loss drugs like GLP-1 receptor agonists and their connection to obesity treatment. The talk explores how metabolic chemicals from exercise influence physical performance and appetite regulation, highlighting the role of lactate and LACFI. Long also touches on the potential of an 'exercise pill' that could mimic exercise's health benefits, raising intriguing possibilities for future therapies.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
INSIGHT

Weight Loss Drugs History

  • GLP-1 receptor agonists, seen in drugs like Ozempic, have revolutionized weight loss.
  • These drugs have a 40-year history, starting from basic endocrinology research in the 1980s.
INSIGHT

Chemical Approach to Exercise

  • Jonathan Long's lab studies exercise by focusing on the molecules produced during physical activity.
  • They use these molecules to understand complex physiological processes.
INSIGHT

Lac-Phe in Various Species

  • The exercise-induced metabolite Lac-Phe, which suppresses appetite, is found in various species.
  • This suggests a conserved mechanism related to physical activity and hunger.
Get the Snipd Podcast app to discover more snips from this episode
Get the app